Who invested in Mironid

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 3 months ago

Funding summaryUpdated 26 Oct 2026

$99Mraised across 3 rounds since 2023, from 3 sources

$10MSeries A$43MSeries B$46MSeries B

Latest round: Series B, $46MAug 2026
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202420252026

$10MSeries A$43MSeries B$46MSeries B

First round: Series A, $10M
Biggest round: $46M
Usual gap between rounds: 3 years

The rounds

Aug 2026
Series B$46M2 new
- Sofinnova Partners
- European Investment Fund
Source recorded
Apr 2026
Series B$43M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Mar 2023
Series A$10M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Founders and team

From Mironid's own website: 5 on the team.

Dr Neil Wilkie PhDChief Executive Officer
Anja HarmeierHead of Roche Venture Fund
Dr Julia Adam PhDHead of Medicinal Chemistry
Richard BrooksHead of Finance
Dr Elaine V. Jones PhDChairman

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2023Series B2026Series B2026

Sofinnova Partners

European Investment Fund

Everyone who backed them

Sofinnova PartnersVC firm1round

European Investment FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Mironid as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.